Development Pipeline
Aiding in the control of infectious diseases
  • Antibody Therapeutics

    Includes our macaque or human derived mAbs and engineered fusion mAbs with host-cell targeting capabilities

    READ MORE
  • Vaccines

    Includes our engineered single or multi-component adjuvanted vaccines providing broad spectrum neutralization capabilities

    READ MORE
Awesome Video Gallery
AbVacc
BIOTECHNOLOGY FOR TODAY AND TOMORROW

AbVacc is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.

We are located in the BioCapital region since 2008.

Science
PROTECTION AGAINST INFECTIONS

Infectious diseases naturally impact human health but also create economical and social shockwaves as evidenced during the COVID era.

AbVacc is committed to developing intelligent solutions to provide broad-range protection against infections caused by emerging viral or antibiotic-resistant bacterial targets.

  • 05
    Viral
    Targets
  • 03
    Bacterial
    Targets
Awesome Video Gallery
People
LEADERSHIP AND DIVERSE EXPERTISE

AbVacc brings together strong leadership and diverse expertise in the areas of protein engineering, immunology, vaccinology, virology, bacteriology and product development.

Connect

(877) 411- 2041
(301) 515-0324
4 Research Ct, Suite 310 Rockville, MD 20850
info@abvacc.com